In 2005, Kim et al. found that emodin can effectively inhibit HA-induced MMP9 secretion and invasion of glioma by inhibiting the activation of FAK, ERK1/2 and Akt/PKB, as well as the transcriptional activities of AP-1 and NF-κB 223. The gene discussed is AKT1; the disease is central nervous system cancer.